RhoA/Rho-kinase in erectile tissue: Mechanisms of disease and therapeutic insights

Clinical Science

Volumn 110, Issue 2, 2006, Pages 153-165

  Jin, Liming ^a   Burnett, Arthur L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corpus cavernosum; Erectile dysfunction; Penis; Rho kinase; RhoA; Smooth muscle

Indexed keywords

CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN PHOSPHATASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

AGING; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENZYME INHIBITION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; HYPOGONADISM; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SEXUAL FUNCTION; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

FEMALE; HUMANS; IMPOTENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; PROTEIN-SERINE-THREONINE KINASES; RHOA GTP-BINDING PROTEIN; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 32644449489     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050255     Document Type: Review

References (149)

1. Ayta, I. A., Mckinlay, J. B. and Krane, R. J. (1999) The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int. 84, 50-56
2. Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. and McKinlay, J. B. (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54-61
3. Burnett, A. L. (2003) Neurophysiology of erectile function: androgenic effects. J. Androl. 24, S2-S5
4. Andersson, K. E. and Wagner, G. (1995) Physiology of penile erection. Physiol. Rev. 75, 191-236
5. Burnett, A. L. (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int. J. Impot. Res. 16(Suppl. 1), S15-S19
6. Burnett, A. L. (1995) Role of nitric oxide in the physiology of erection. Biol. Reprod. 52, 485-489
7. Webb, R. C. (2003) Smooth muscle contraction and relaxation. Adv. Physiol. Edu. 27, 201-206
8. Karaki, H., Ozaki, H., Hori, M. et al. (1997) Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 49, 157-230
9. Somlyo, A. P. and Somlyo, A. V. (2002) The sarcoplasmic reticulum: then and now. Novartis Found. Symp. 246, 258-268
10. DeFeo, T. T. and Morgan, K. G. (1985) Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. J. Physiol. 369, 269-282
11. 2+ sensitivity in α-toxin permeabilized arterial smooth muscle. Biochem. Biophys. Res. Commun. 157, 677-683
12. Somlyo, A. P. and Somlyo, A. V. (1994) Signal transduction and regulation in smooth muscle. Nature (London) 372, 231-236
13. Hartshorne, D. J., Ito, M. and Erdodi, F. (1998) Myosin light chain phosphatase: subunit composition, interactions and regulation. J. Muscle Res. Cell Motil. 19, 325-341
14. Hirata, K., Kikuchi, A., Sasaki, T. et al. (1992) Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J. Biol. Chem. 267, 8719-8722
15. Burridge, K. and Wennerberg, K. (2004) Rho and Rac take center stage. Cell 116, 167-179
16. Chen, Z., Sun, J., Pradines, A., Favre, G., Adnane, J. and Sebti, S. M. (2000) Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J. Biol. Chem. 275, 17974-17978
17. Clark, E. A., Golub, T. R., Lander, E. S. and Hynes, R. O. (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature (London) 406, 532-535
18. Ridley, A. J. and Hall, A. (1992) The small GTP-hinding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389-399
19. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325-1358
20. Bishop, A. L. and Hall, A. (2000) Rho GTPases and their effector proteins. Biochem. J. 348, 241-255
21. Schwartz, M. (2004) Rho signalling at a glance. J. Cell Sci. 117, 5457-5458
22. Narumiya, S. (1996) The small GTPase Rho: cellular functions and signal transduction. J. Biochem. (Tokyo) 120, 215-228
23. Takai, Y., Sasaki, T., Tanaka, K. and Nakanishi, M. (1995) Rho as a regulator of the cytoskeleton. Trends Biochem. Sci. 20, 227-231
24. Van Aelst, L. and D'Souza-Schorey, C. (1997) Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322
25. Lamarche, N. and Hall, A. (1994) GAPs for Rho-related GTPases. Trends Genet. 10, 436-440
26. Olofsson, B. (1999) Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell. Signalling 11, 545-554
27. Sasaki, T., Kato, M. and Takai, Y. (1993) Consequences of weak interaction of Rho GDI with the GTP-bound forms of Rho p21 and Rac p21. J. Biol. Chem. 268, 23959-23963
28. Wei, L., Imanaka-Yoshida, K., Wang, L. et al. (2002) Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development 129, 1705-1714
29. 2+ sensitization of smooth muscle myosin II. Am. J. Physiol. Cell Physiol. 281, C257-C269
30. Bilodeau, D., Lamy, S., Desrosiers, R. R., Gingras, D. and Beliveau, R. (1999) Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions. Biochem. Cell Biol. 77, 59-69
31. Lang, P., Gesbert, F., Delespine-Carmagnat, M., Stancou, R., Pouchelet, M. and Bertoglio, J. (1996) Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15, 510-519
32. Tamma, G., Klussmann, E., Procino, G., Svelto, M., Rosenthal, W. and Valenti, G. (2003) cAMP-induced AQP2 translocation is associated with RhoA inhibition through RhoA phosphorylation and interaction with RhoGDI. J. Cell Sci. 116, 1519-1525
33. Qiao, J., Huang, F. and Lum, H. (2003) PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am. J. Physiol. Lung Cell Mol. Physiol. 284, L972-L980
34. 2+ sensitization pathway in smooth muscle. Structure 12, 1955-1965
35. Zheng, Y. (2001) Dbl family guanine nucleotide exchange factors. Trends Biochem. Sci. 26, 724-732
36. Cerione, R. A. and Xheng, Y. (1996) The Dbl family of oncogenes. Curr. Opm. Cell Biol. 8, 216-222
37. Blomberg, N., Baraldi, E., Nilges, M. and Saraste, M. (1999) The PH superfold: a structural scaffold for multiple functions. Trends Biochem. Sci. 24, 441-445
38. Kristelly, R., Gao, G. and Tesmer, J. J. G. (2004) Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor. J. Biol. Chem. 279, 47352-47362
39. Hollinger, S. and Hepler, J. R. (2002) Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54, 527-559
40. 13 as key regulatory mediator in signal transduction. Life Sci. 74, 155-161
41. 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc. Natl. Acad. Sci. U.S.A. 100, 733-738
42. 13. Science 280, 2112-2114
43. Fukuhara, S., Murga, C., Zohar, M., Igishi, T. and Gutkind, J. S. (1999) A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric C proteins to Rho. J. Biol. Chem. 274, 5868-1879
44. 13 mutations that disrupt interaction with p115RhoGEF. Oncogene 24, 2155-2165
45. 13 for regulation of p115RhoGEF and leukemia-associated RhoGEF. Mol. Pharmacol. 66, 1029-1034
46. Booden, M. A., Siderovski, D. P. and Der, C. J. (2002) Leukemia-associated Rho guanine nucleotide exchange factor promotes Gaq-coupled activation of RhoA. Mol. Cell. Biol. 22, 4053-4061
47. q-coupled receptors. J. Biol. Chem. 277, 27130-27134
48. Fukuhara, S., Chikumi, H. and Gutkind, J. S. (2001) RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho? Oncogene 20, 1661-1668
49. Holinstat, M., Mehta, D., Kozasa, T., Minshall, R. D. and Malik, A. B. (2003) Protein kinase Co-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangement. J. Biol. Chem. 278, 28793-28798
50. Rittinger, K., Walker, P. A., Eccleston, J. F. et al. (1997) Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP. Nature (London) 388, 693-697
51. Haskell, M., Nickles, A., Agati, J., Su, L., Dukes, B. and Parsons, S. (2001) Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J. Cell Sci. 114, 1699-1708
52. Homma, Y. and Emori, Y. (1995) A dual functional signal mediator showing RhoGAP and phospholipase C-δ stimulating activities. EMBO J. 14, 286-291
53. Taylor, J. M., Hildebrand, J. D., Mack, C. P., Cox, M. E. and Parsons, J. T. (1998) Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase. J. Biol. Chem. 273, 8063-8070
54. Billuart, P., Winter, C. G., Maresh, A., Zhao, X. and Luo, L. (2001) Regulating axon branch stability: the role of p190 RhoGAP in repressing a retraction signaling pathway. Cell 107, 195-207
55. Amano, M., Fukata, Y. and Kaibuchi, K. (2000) Regulation and functions of Rho-associated kinase. Exp. Cell Res. 261, 44-51
56. Chen, X.-q., Tan, I., Ng, C. H., Hall, C., Lim, L. and Leung, T. (2002) Characterization of RhoA-binding kinase ROKα: implication of the pleckstrin homology domain in ROKα function using region-specific antibodies. J. Biol. Chem. 277, 12680-12688
57. Ito, M., Nakano, T., Erdodi, F. and Hartshorne, D. J. (2004) Myosin phosphatase: structure, regulation and function. Mol. Cell. Biochem. 259, 197-209
58. Tanaka, J., Ito, M., Feng, J. et al. (1998) Interaction of myosin phosphatase target subunit 1 with the catalytic subunit of type 1 protein phosphatase. Biochemistry 37, 16697-16703
59. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83, 1325-1358
60. Somlyo, A. P. and Somlyo, A. V. (2000) Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J. Physiol. 522, 177-185
61. Feng, J., Ito, M., Ichikawa, K. et al. (1999) Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 274, 37385-37390
62. Kimura, K., Ito, M., Amano, M. et al. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273, 245-248
63. 2α-induced contraction of rabbit aortae. J. Physiol. 546, 823-836
64. 2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem. J. 389, 763-774
65. 2+- sensitization of chicken amnion smooth muscle lacking CPI-17. FEBS Lett. 578, 73-79
66. Velasco, G., Armstrong, C., Morrice, N., Frame, S. and Cohen, P. (2002) Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin. FEBS Lett. 527, 101-104
67. 2+ sensitization of smooth muscle contraction through activation of Rho-kinase. Pflugers Arch. 441, 596-603
68. 2+-sensitization of smooth muscle. FEBS Lett. 440, 183-187
69. Chardin, P. (2003) GTPase regulation getting aRnd Rock and Rho inhibition. Curr. Biol. 13, R702-R704
70. Riento, K., Villalonga, P., Garg, R. and Ridley, A. (2005) Function and regulation of RhoE. Biochem. Soc. Trans. 33, 649-651
71. Riento, K., Guasch, R. M., Garg, R., Jin, B. and Ridley, A. J. (2003) RhoE binds to ROCK I and inhibits downstream signaling. Mol. Cell. Biol. 23, 4219-4229
72. Wennerberg, K., Forget, M.-A., Ellerbroek, S. M., Arthur, W. T., Burridge, K., Settleman, J., Der, C. J. and Hansen, S. H. (2003) Rnd proteins function as RhoA antagonists by activating p190RhoGAP. Curr. Biol. 13, 1106-1115
73. Li, L., Eto, M., Lee, M. R., Morita, F., Yazawa, M. and Kitazawa, T. (1998) Possible involvement of the novel CPI-17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle. J. Physiol. 508, 871-881
74. Hayashi, Y., Senba, S., Yazawa, M., Brautigan, D. L. and Eto, M. (2001) Defining the structural determinants and a potential mechanism for inhibition of myosin phosphatase by the protein kinase C-potentiated inhibitor protein of 17 kDa. J. Biol. Chem. 276, 39858-39863
75. Eto, M., Senba, S., Morita, F. and Yazawa, M. (1997) Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett. 410, 356-360
76. Eto, M., Ohmori, T., Suzuki, M., Furuya, K. and Morita, F. (1995) A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J. Biochem. (Tokyo) 118, 1104-1107
77. Matsuzawa, F., Aikawa, S.-i., Ohki, S.-y. and Eto, M. (2005) Phospho-pivot modeling predicts specific interactions of protein phosphatase-1 with a phospho-inhibitor protein CPI-17. J. Biochem. (Tokyo) 137, 633-641
78. Eto, M., Kitazawa, T., Yazawa, M., Mukai, H., Ono, Y. and Brautigan, D. L. (2001) Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase Cα and δ isoforms. J. Biol. Chem. 276, 29072-29078
79. Koyama, M., Ito, M., Feng, J., Seko, T., Shiraki, K., Takase, K., Hartshorne, D. J. and Nakano, T. (2000) Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett. 475, 197-200
80. Pang, H., Guo, Z., Su, W., Xie, Z., Eto, M. and Gong, M. C. (2005) RhoA/Rho kinase mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 289, C352-C360
81. Chitaley, K. and Webb, R. C. (2002) Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 39, 438-442
82. Carter, R. W., Begaye, M. and Kanagy, N. L. (2002) Acute and chronic NOS inhibition enhances α2-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 283, H1361-H1369
83. 2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 275, 21722-21729
84. Sawada, N., Itoh, H., Yamashita, J. et al. (2001) cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem. Biophys. Res. Commun. 280, 798-805
85. Sauzeau, V., Rolli-Derkinderen, M., Marionneau, C., Loirand, G. and Pacaud, P. (2003) RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J. Biol. Chem. 278, 9472-9480
86. Ming, X. F., Viswambharan, H., Barandier, C. et al. (2002) Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell. Biol. 22, 8467-8477
87. Mita, S., Kobayashi, N., Yoshida, K., Nakano, S. and Matsuoka, H. (2005) Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats. J. Hypertens. 23, 87-96
88. Genth, H., Gerhard, R., Maeda, A. et al. (2003) Entrapment of Rho ADP-ribosylated by clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex. J. Biol. Chem. 278, 28523-28527
89. Sehr, P., Joseph, G., Genth, H., Just, I., Pick, F., and Aktories, K. (1998) Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37, 5296-5304
90. Genth, H., Schmidt, M., Gerhard, R., Aktories, K. and Just, I. (2003) Activation of phospholipase D1 by ADP-ribosylated RhoA. Biochem. Biophys. Res. Commun. 302, 127-132
91. Fujihara, H., Walker, L. A., Gong, M. C. et al. (1997) Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol. Biol. Cell 8, 2437-2447
92. Aktories, K., Schmidt, G. and Just, I. (2000) Rho GTPases as targets of bacterial protein toxins. Biol. Chem. 381, 421-426
93. Boquet, P. (1999) Bacterial toxins inhibiting or activating small GTP-binding proteins. Ann. NY Acad. Sci. 886, 83-90
94. Aktories, K. and Schmidt, G. (2003) A new turn in Rho GTPase activation by Escherichia coli cytotoxic necrotizing factors. Trends Microbiol. 11, 152-155
95. Hoffmann, C., Pop, M., Leemhuis, J., Schirmer, J., Aktories, K. and Schmidt, G. (2004) The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J. Biol. Chem. 279, 16026-16032
96. Ishizaki, T., Uehata, M., Tamechika, I. et al. (2000) Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol. Pharmacol. 57, 976-983
97. Uehata, M., Ishizaki, T., Satoh, H. et al. (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (London) 389, 990-994
98. 2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L1218-L1224
99. Sakamoto, K., Hori, M., Izumi, M. et al. (2003) Inhibition of high K+-induced contraction by the ROCKs inhibitor Y-27632 in vascular smooth muscle: possible involvement of ROCKs in a signal transduction pathway. J. Pharmacol. Sci. 92, 56-69
100. Nagumo, H., Sasaki, Y., Ono, Y., Okamoto, H., Seto, M. and Takuwa, Y. (2000) Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am. J. Physiol. Cell Physiol. 278, C57-C65
101. Sasaki, Y., Suzuki, M. and Hidaka, H. (2002) The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]- homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol. Ther. 93, 225-232
102. Feig, L. A. (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat. Cell Biol. 1, E25-E27
103. Pawlak, G. and Helfman, D. M. (2002) Post-transcriptional down-regulation of ROCK1/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. Mol. Biol. Cell 13, 336-347
104. Morishige, K., Shimokawa, H., Eto, Y. et al. (2001) Adenovirus-mediated transfer of dominant-negative Rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler., Thromb., Vasc. Biol. 21, 548-554
105. Pille, J.-Y., Denoyelle, C., Varet, J. et al. (2005) Anti-RhoA and Anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol. Ther. 11, 267-274
106. Deroanne, C., Vouret-Craviari, V., Wang, B. and Pouyssegur, J. (2003) EphrinA1 inactivates integrin-mediated vascular smooth muscle cell spreading via the Rac/PAK pathway. J. Cell Sci. 116, 1367-1376
107. Chitaley, K., Wingard, C. J., Webb, R. C. et al. (2001) Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat. Med. 7, 119-122
108. Rees, R. W., Ziessen, T., Ralph, D. J., Kell, P., Moncada, S. and Cellek, S. (2002) Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int. J. Impot. Res. 14, 1-7
109. 2+ sensitization in erectile function. J. Biol. Chem. 277, 30614-30621
110. Chitaley, K., Bivalacqua, T. J., Champion, H. C. et al. (2002) Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem. Biophys. Res. Commun. 298, 427-432
111. Andersson, K.-E. (2001) Pharmacology of penile erection. Pharmacol. Rev. 53, 417-450
112. Jin, L., Under, A. E., Mills, T. M. and Webb, R. C. (2003) Inhibition of the tonic contraction in the treatment of erectile dysfunction. Fxpert Opin. Then Targets 7, 265-276
113. Rees, R. W., Ralph, D. J., Royle, M., Moncada, S. and Cellek, S. (2001) Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br. J. Pharmacol. 133, 455-458
114. Wingard, C. J., Husain, S., Williams, J. and James, S. (2003) RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 285, R1145-R1152
115. Mills, T. M., Chitaley, K., Wingard, C. J., Lewis, R. W. and Webb, R. C. (2001) Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J. Appl. Physiol. 91, 1269-1273
116. 2+ sensitivity regulates contractility of rabbit corpus cavernosum smooth muscle. J. Urol. 169, 2412-2416
117. Husain, S., Young, D. and Wingard, C. J. (2004) Role of PKCα and PKCι in phenylephrine-induced contraction of rat corpora cavernosa. Int. J. Impot. Res. 16, 325-333
118. Mills, T. M., Chitaley, K., Lewis, R. W. and Webb, R. C. (2002) Nitric oxide inhibits RhoA/Rho-kinase signaling to cause penile erection. Eur. J. Pharmacol. 439, 173-174
119. Teixeira, C. E., Ying, Z. and Webb, R. C. (2005) Pro-erectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl] homopiperazine (H-1152) in the rat penis. J. Pharmacol. Exp. Ther. 315, 155-162
120. Bivalacqua, T. J., Champion, H. C., Usta, M. F. et al. (2004) RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc. Natl. Acad. Sci. U.S.A. 101, 9121-9126
121. Muller, S. C., el-Damanhoury, H., Ruth, J. and Lue, T. F. (1991) Hypertension and impotence. Eur. Urol. 19, 29-34
122. Burchardt, M., Burchardt, T., Baer, L. et al. (2000) Hypertension is associated with severe erectile dysfunction. J. Urol. 164, 1188-1191
123. Rosen, R. C., Fisher, W. A., Eardley, I., Niederberger, C., Nadel, A. and Sand, M. (2004) The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr. Med. Res. Opin. 20, 607-617
124. Jensen, J., Lendorf, A., Stimpel, H., Frost, J., Ibsen, H. and Rosenkilde, P. (1999) The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am. J. Hypertens. 12, 271-275
125. Toblli, J. E., Stella, I., Inserra, F., Ferder, L., Zeller, F. and Mazza, O. N. (2000) Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am. J. Hypertens. 13, 686-692
126. Okabe, H., Hale, T. M., Kumon, H., Heaton, J. P. and Adams, M. A. (1999) The penis is not protected: in hypertension there are vascular changes in the penis which are similar to those in other vascular beds. Int. J. Impot. Res. 11, 133-140
127. Chitaley, K., Webb, R. C., Dorrance, A. M. and Mills, T. M. (2001) Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int. J. Impot. Res. 13 (Suppl. 5), S16-S20
128. Wilkes, N., White, S., Stein, P., Bernie, J. and Rajasekaran, M. (2004) Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats. Int. J. Impot. Res. 16, 187-194
129. Chang, S., Hypolite, J. A., Changolkar, A., Wein, A. J., Chacko, S. and DiSanto, M. E. (2003) Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase β. Int. J. Impot. Res. 15, 53-62
130. Christ, G. J., Lerner, S. E., Kim, D. C. and Melman, A. (1995) Endothelin-1 as a putative modulator of erectile dysfunction: I. Characteristics of contraction of isolated corporal tissue strips. J. Urol. 153, 1998-2003
131. Buyukafsar, K. and Un, I. (2003) Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Eur. J. Pharmacol. 472, 235-238
132. Begum, N., Duddy, N., Sandu, O., Reinzie, J. and Ragolia, L. (2000) Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3- kinase-dependent signaling pathways. Mol. Endocrinol. 14, 1365-1376
133. Sandu, O., Ragolia, L. and Begum, N. (2000) Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49, 2178-2189
134. Shabsigh, R. (2004) Testosterone therapy in erectile dysfunction. Aging Male 7, 312-318
135. Albrecht-Betancourt, M., Hijazi, R. A. and Cunningham, G. R. (2004) Androgen replacement in men with hypogonadism and erectile dysfunction. Endocrine 23, 143-148
136. Mills, T. M., Dai, Y., Stopper, V. S. and Lewis, R. W. (1999) Androgenic maintenance of the erectile response in the rat. Steroids 64, 605-609
137. Wingard, C. J., Johnson, J. A., Holmes, A. and Prikosh, A. (2003) Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 284, R1572-R1579
138. Dai, Y., Chitaley, K., Webb, R. C., Lewis, R. W. and Mills, T. M. (2004) Topical application of a Rho-kinase inhibitor in rats causes penile erection. Int. J. Impot. Res. 16, 294-298
139. Garban, H., Marquez, D., Cai, L., Rajfer, J. and Gonzalez-Cadavid, N. (1995) Restoration of normal adult penile erectile response in aged rats by long-term treatment with androgens. Biol. Reprod. 53, 1365-1372
140. Carrier, S., Nagaraju, P., Morgan, D. M., Baba, K., Nunes, L. and Lue, T. F. (1997) Age decreases nitric oxide synthase-containing nerve fibers in the rat penis. J. Urol. 157, 1088-1092
141. Rajasekaran, M., Kasyan, A., Jain, A., Kim, S.-W. and Monga, M. (2002) Altered growth factor expression in the aging penis: the Brown-Norway rat model. J. Androl. 23, 393-399
142. .- and improves erectile function in aged rats. Am. J. Physiol. Heart Circ. Physiol. 284, H1408-H1421
143. Champion, H. C., Bivalacqua, T. J., Hyman, A. L., Ignarro, L. J., Hellstrom, W. J. G. and Kadowitz, P. J. (1999) Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc. Natl. Acad. Sci. U.S.A. 96, 11648-11652
144. Rajasekaran, M., White, S., Baquir, A. and Wilkes, N. (2005) Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats. J. Androl. 26, 182-188
145. Jin, L., Liu, T., Lagoda, G. A., Champion, H. C., Bivalacqua, T. J. and Burnett, A. L. (2005) Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. FASEB J., in the press
146. Cellek, S. (2003) The Rho-kinase inhibitor Y-27632 and the soluble guanylyl cyclase activator BAY41-B2272 relax rabbit vaginal wall and clitoral corpus cavernosum. Br. J. Pharmacol. 138, 287-290
147. Park, J. K., Lee, S. O., Kim, Y. G., Kim, S. H., Koh, G. Y. and Cho, K. W. (2002) Role of rho-kinase activity in angiotensin II-mduced contraction of rabbit clitoral cavernosum smooth muscle. Int. J. Impot. Res. 14, 472-477
148. Bi, D., Nishimura, J., Niiro, N., Hirano, K. and Kanaide, H. (2005) Contractile properties of the cultured vascular smooth muscle cells: the crucial role played by RhoA in the regulation of contractility. Circ. Res. 96, 890-897
149. 2+ sensitization and the regulation of contractility in rat anococcygeus and retractor penis muscle. Biochem. Pharmacol. 69, 1483-1492